Peter Walsh

George Sun

Screened

Mid-level investor specializing in cross-border private equity and tech

Cambridge, MA4y exp

“Investor/banker with cross-border sourcing experience spanning JPMorgan, Ascendant, Pumavira, and EQD, covering AI, advanced manufacturing, TMT, and consumer healthcare. Stands out for turning cold founder outreach into long-term banking engagements and for combining high-volume sourcing with rigorous early-stage commercial and regulatory screening.”

“Life sciences business development leader with experience as Head of Business Development at Praxis Precision Medicines, leveraging VC relationships to source value-accretive opportunities such as a partnership with Cerebral Therapeutics. Demonstrates a founder-oriented mindset and unusually rigorous biotech opportunity assessment, including nuanced evaluation of mechanism, preclinical data, and compounded biology/technology risk.”

“Senior technology and venture-oriented leader pursuing a CTO role, with hands-on experience advising an AI startup and a VC firm while also building incubation and technology advisory functions at Iron Mountain. Notably brought a cybersecurity product to market in six months and helped position a blockchain product through early deal development, showing a strong blend of product, strategy, and venture-building capability.”

Edward Robinson-Adams

Screened

Executive cybersecurity and AI leader, CEO/co-founder specializing in enterprise SaaS and strategy

Boston, MA35y exp

“Operator who took a seed-funded university spin-off in cybersecurity from zero revenue and heavy losses to profitability and industry leadership, while building the full internal ops stack (HR/payroll/benefits/401k) and the initial GTM engine (Salesforce/HubSpot, SPIN + MEDPICC). Personally led fundraising across 30+ VC pitches, raising $11.2M total and delivering $98M returned to investors to date, with additional upside from a subsequent spin-off.”